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Summary.-Cell-mediated and humoral immune responses to Herpesvirus hominis
type 1 (HVH1) and Candida albicans were studied in patients with leukoplakia,
showing a histological spectrum of changes from epithelial keratosis to acanthosis
and atypia, and in patients with carcinoma. The results were ranked according to
increasing values of stimulation indices of lymphocyte transformation to HVH1,
and the corresponding macrophage migration inhibition indices, and complement
fixing antibody titres of each patient were correlated. This revealed that most
patients with epithelial atypia were clustered to that end of the spectrum which had
the highest stimulation and migration indices to HVH1; this relationship was not
evident with C. albicans. In patients with keratosis and acanthosis there was a
significant lack of correlation between lymphocyte transformation and migration
inhibition to both HVH1 and C. albicans. In carcinoma the indices of lymphocyte
transformation and migration inhibition to HVH1 and C. albicans were depressed.
Furthermore, a significant negative correlation was found between lymphocyte
transformation and migration inhibition to HVH1, unlike the positive correlation in
control subjects. Complement fixing antibodies to HVH1, HVH2, cytomegalovirus
and adenovirus, and fluorescent antibodies to C. albicans failed to show a significant
change in titre in any one group of subjects tested. The results suggest a cell-
mediated immune defect in leukoplakia, with a dissociation between lymphocyte
transformation and macrophage migration inhibition to HVH1 and C. albicans in
cases of keratosis or acanthosis. A specific increase in cell-mediated immunity to
HVH1 in leukoplakia with epithelial atypia and the sequential changes argue in
favour of a possible participation of HVHl in carcinomatous transformation of some
leukoplakias.
THE aetiology of most oral leuko-
plakias is unknown but it appears that a
variety of aetiological agents may be
involved, suchas smoking, friction, syphilis
and chronic candidiasis. Leukoplakia
undergoes carcinomatous transformation
in about 5% of patients (Kramer et al.,
1970), and it is the precancerous nature
of some of these lesions that makes it an
important condition for investigation.
An immunopathological investigation of
this disease revealed that saline homogen-
ates of leukoplakic tissue induce slight
stimulation of autologous lymphocytes
(Lehner, 1970a). A significant negative
correlation was found between [14C]
thymidine uptake of lymphocytes in vitro
and the non-pyroninophilic mononuclear
cell infiltration in biopsies ofleukoplakias.
There appeared to be a progressive im-
pairment of lymphocyte stimulation with
histological grading of leukoplakia, from
keratosis to acanthosis, epithelial atypia
and carcinoma. Furthermore, a signifi-
cant rise in non-pyroninophilic and pyro-
ninophilic cells was found in the histologi-
cally graded biopsies (Lehner, 1971).
These results suggested that in leukoplakia
carcinomatous transformation may be
associated with some immunological
changes.
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assess the cellular andl humoral immune
responses to Herpesvirus hominis type 1
(HVIIl) in patients with leukoplakia
showing a histological spectrum of in-
creasing severity, and in carcinoma.
These results were then compared with a
series of cointrol subjects and with the
responses to C(andida albicans. HVH1
was selected for this study as it is the most
commonly found virus in the mouth,
causing infection in infancy or childhood
and a high incidence ofrecurrences. These
are associated with an impaired macro-
phage migration inhibition and cytotoxic
function of lymphocytes, in the presence
of normal lymphocyte transformation and
antibody responses (Wilton, Ivanyi and
Lehner, 1972). Although the virus has
no proven oncogenic properties, it may
enhance papilloma and carcinoma forma-
tion when administeredl with methyl-
cholanthrene (Tanaka and Southam, 1965;
Southam et al., 1969), so that some
co-carcinogen properties cannot be ex-
cluded. C'. albicans was used because it
is a common carrier fungus of the mouth
andmay cause aspecifictypeofleukoplakia
termed chronic hyperplastic candidiasis
(Cawson and Lehner, 1968).
MATERIALS AND METHODS
Patients. A series of 45 patients wNas
classified on clinical and histological criteria
of biopsies into the folloNing: (a) 32 patients
whose leukoplakia was graded histologically
into epithelial keratosis (12), acanthosis (13),
and atypia (7), and (b) 13 patients with
carcinoma (Lehner, 1970a). The control
series consisted of 30 normal subjects,
matched for age and sex. The term leuko-
plakia was applied to white lesions that
cannot be assigned to any other diagnostic
category. Most ofthe carcinomata were at a
very early stage of invasion and only one
patient had lymph node metastases; all
immunological tests were carried out before
treatment commenced.
Antigens. Optimal dilutions and, when-
ever sufficient number of lymphocytes were
available, serial dilutions of each of the
following agents were added to the leucocyte
cultures: Herpesvirus hominis type 1 (com-
plementfixingantigen; Public Health Labora-
tories), PHA (Welleome Reagents) and 10%
extract of Candida albicani,s containing 15 mg
protein/ml (Bencard).
Lymphocyte transformation test.-Lym-
phocyte cultures were prepared in duplicate
or triplicate in the presence of 10% auto-
logous or foetal calf serum (FCS; Rehatuin
F.S., Armour Pharmaceutical Co. Ltd.) and
were harvested after 4 days and assessed by
the method described previously (Ivanyi and
Lehner, 1970). The results were expressed in
terms of the stimulation index (SI), as the
ratio of ['4C] thymidine uptake in antigen-
stimulated and control cultures. A SI
greater than 2-0 was considered to be signifi-
cant, except for HVH1 in autologous serum
when a SI greater than 3 0 was taken as a
significant value. The results of lymphocyte
stimulation are given only for cultures in
autologous serum, but comparable though
decreased S1 were found with lymphocytes in
FCS.
Macrophage migration inhibition test.
This was performed by the indirect method
of Thor et al. (1968). Supernatants from
lymphocyte cultures were tested with 4
capillary tubes filled with guinea-pig peri-
toneal cells induced by injection of paraffin
oil as described elsewhere (Ivanyi, Wilton
and Lehner, 1972). The migration index
(MI) was calculated as the percentage ratio
betwAeen the migration area in antigen-
stimulated culture supernatant and that of
saline control reconstituted with the antigen
(Dumonde, 1970). A Ml less than 80% was
considered to be significant.
Complement fixing antibody test (OFA).
This was performed by the method of Brad-
street'and Taylor (1962). The antigens used
were Herpesvirus hominis type 1 and type 2,
Adenovirus (Public Health Laboratories),
cytomegalovirus (Flow Laboratories, Irvine,
Scotland). A titre greater than 1 : 5 was
taken as a significant level.
Fluorescent antibody test (FAT).-IgG
class of antibodies to C. albicans were
estimated by the method described previously
(Lehner, 1966, 1970b).
Sequential changes over a period of 3
years have been followed in one patient in
whom leukoplakia of the cheek changed from
epithelial atypia to carcinoma, at all stages
of which the diagnoses were based on biopsy
examination.
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RESULTS
The results were ranked according to
the SI of lymphocytes stimulated by
HVHI and the corresponding MI and
CFA were plotted vertically (Fig. 1).
Controls showed significant correlation
between lymphocyte transformation and
both migration inhibition (X2 7 58;
P < 0.01) and complement fixing anti-
bodies (X2 11.25; P < 0.001). In
patients with leukoplakia (Fig. 2) the
correlations between SI, MI and CFA
were not maintained. Further analysis
ofthe leukoplakia series into 3 histological
groups revealed that all 7 cases of epithe-
lial atypia were clustered to the upper end
of the spectrum and that a significant
MI was found in all 5 tested (Fig. 2).
There was no obvious immunological
differentiation of leukoplakia with kera-
tosis from that with acanthosis so these
were combine(d an(l the resulting grou)
showed a lack of correlation between
lymphocyte transformation, macrophage
migration inhibition and complement fix-
ing antibodies.
The response of lymphocytes to C.
albicans was similarly analysed and in the
control series the SI was correlated with
the MI (r 0*43; P 0.05), but not with
the FAT (Fig. 3). In leukoplakia there
was a dissociation between lymphocyte
transformation, migration inhibition and
fluorescent antibodies and patients with
epithelial atypia were not clustered to one
end of the spectrum (Fig. 4).
Lymphocyte transformation test
A depressed SI to HVH was found in
patients with leukoplakia showing kera-
tosis or acanthosis as compared with the
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FIG. 2.-Comparison of indices of lymphocyte transformation, macrophage migration inhibition and complement fixing antibodies to Herpe8viru8 type in patients with leukoplakia and carcinoma.
controls (Table I); this reached the 5%
level ofsignificance only if a high SI (> 7)
was analysed (x2 = 4-1; P < 0*05). Lym-
phocytes from patients with atypia, how-
ever, showed a significant increase in the
SI compared with those from the control
group, even at the lower baseline St of
> 3 (X2 3-99; P < 0.02). A signifi- cantly impaired response to HVH1 was
also found in carcinoma (X2 - 5*36; P <
0.05). Comparable results were found
with lymphocytes cultured in the presence
of FCS, though the actual values of SI
were much lower. The response of lym-
phocytes to C. albican2 was decreased in
all groups, including atypia, compared with controls, but only lymphocytes from
patients with carcinoma showed a signifi-
cant depression in SI (x2
= 4.7; P <
0.05).
The results of lymphocyte stimulation
with PHA were expressed as a percentage
of SI of a group of normal subjects tested
during the same period oftime, in order to
avoid the variation found with PHA
stimulation. A significant change was
not found between the patients tested
(Fig. 5).
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TABLE I.-Immunological Indices to HVHI, Candida albicans and PHA
in 3 Groups ofPatients and Controls
Keratosis-
,anism Test Control acanthosis Atypia Carci
)d in (1) 30 25 7 1
rU8 (1) Lymphocyte 8*5±2*34 3*8±O* 75 20 8±9* 62 1*9+
transformation*
(2) Migration 13/26 (50%) 11/23 (48%) 5/5 (100%) 2/9 (2
inhibitiont
(3) Complement 12/30 (40%) 13/25 (52%) 5/7 (71%) 6/13 (
fixationj )d in (4) 22 23 7 1 albican8 (4) Lymphocyte 3*8±1-16 2 9±10 1b9±0*95 1.5±
transformation
(5) Migration 10/20 (50%) 5/18 (28%) 2/4 (50%) 3/8 (3
inhibition
(6) Fluorescent§ 3/21 (14%) 2/20 (10%) 2/7 (29%) 6/13
antibody
(7) Lymphocyte 104±29*3 124±51. 6 105+
A. _ - -.0- _.- _ ,,-I-- transformationll
* Expressed as mean ± standard error.
t Significant index < 80.
t Significant antibody > 1: 5.
§ Significant IgG class of antibodies > 1: 8.
1I Given as per cent mean of normal, + standard error.
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FIG. 4. Comparison of indices of lymphocyte transformation, macrophage migration inhibition and
fluorescent antibody titre to Candida albiccans in patients with leukoplakia and carcinoma.
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Macrophage migration inhibition test
The results were comparable with
those found in the lymphocyte transforma-
tion test, in that all 5 patients with atypia
testedhadaMIoflessthan80%andpatients
with carcinoma showed a lower incidence
of significant MI than controls (Table I).
However, no difference in the incidence of
significant MI was observed in patients
with keratosis and acanthosis when com-
pared with controls. A significant differ-
ence in MI between the 4 groups of
subjects was not observed when lympho-
cytes were stimulated with C. albicans
(Table I).
Conmplement fixing antibody test
The number of patients with a serum
antibody titre greater than 1: 5 was not
significantly different in any one group of
patients when compared with controls
(Table I), though again patients in the
atypia group showed the highest incidence
of raised antibodies. Complement fixing
antibodies to HVH2, cytomegalovirus and
adenovirus failed to show a significant
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relationship to the various groups of
patients.
Fluorescent antibodies to C. albicans
The prevalence of a titre greater than
1: 8 was slightly higher in atypia and
further increased in carcinoma, though the
5% level of significance was not reached
(Table I).
Sequential changes of lymphocyte
transformation to HVH1, C. albicans and
PHA, and CFA to HVH1 are shown in
Fig. 6. At the stage of epithelial atypia
the SI toHVHl was 14.5 andthisfell to 1-7
when the diagnosis of a well-differentiated
squamous cell carcinoma was made.
After radiotherapy treatment the SI rose
to 3*9 but fell to below 1 with the appear-
anceofrecurrentcarcinomata. Duringthe
entire period the CFA titre of less than
1: 5 remained unchanged. C. albicans
showed an increase in the SI from 1 7 at
the epithelial atypia stage to 3*2 when
carcinoma was diagnosed, with further
increase to 5-6 after radiotherapy but a
fall to 1*5 with the development of
recurrent carcinoma. Oral candida infec-
tion was diagnosed 3 months before the
appearance ofthe first carcinoma and this
was presumably responsible for the in-
creased SI to C. albicans. The response
to PHA was 46% of normal during
epithelial atypia and carcinoma. It in-
creased to 61% after radiotherapy but
showed a dramatic fall to 6% and 3%
afterthesecondandthirdrecurrence ofcar-
cinoma. Although the carcinoma showed
extensive local invasion and became
inoperable, lymph node metastases were
not clinically detectable. Cytotoxic drugs
were administered at this stage, bringing
about a moderate regression ofthe tumour.
DISCUSSION
Oral white lesions or leukoplakia can
develop in those chronic infections that
manifest cell-mediated immunodeficien-
cies; syphilis (Levene, Wright and Turk,
1971) and mucocutaneous candidosis
(Lehner, Wilton and Ivanyi, 1972). In
the present study of idiopathic leuko-
plakia, cell-mediated immunodeficiencies
have been found similar to those observed
in grades B, C and D of chronic hyper-
plastic candidosis. These grades show a
negative migration inhibition withpositive
lymphocyte transformation to C. albicans
and a similar dissociation in cell-mediated
immune functions to HVHi has been
found in 6 patients with leukoplakia
showing keratosis or acanthosis. How-
ever, 7 other patients with the same type
of leukoplakia showed the reverse disso-
ciation, that is intact migration inhibition
activity, in the absence ofsignificant DNA
synthesis, and this has now been also
found in 2 patients with chronic localized
mucocutaneous candidosis with granu-
loma (Goldberg et al., 1971; Valdimarsson
et al., 1970) and in one patient with
chronic hyperplastic candidosis (Lehner
and Wilton, unpublished). Hence, a dis-
sociation between the two functions of
lymphocytes is an immune defect now
foundinpatients with chronichyperplastic
candidosis and leukoplakia, some of
which might be associated with smoking
andothersareidiopathic. Ifbothtypesof
defects, i.e. positive lymphocyte transfor-
mation with negative migration inhibition
and the converse in keratosis-acanthosis,
are comparedwith controlsthensignificant
differences are found with HVHI (X2 5.79; P < 0.02) and to a lesser extent with
C. albicans (X2 - 5.1; P < 0.05). It is
therefore possible that this type of
leukoplakia shows a cell-mediated im-
mune defect which may not be confined to
one antigen.
The immune tests failed to discrimi-
nate between the leukoplakias with kera-
tosis only and those showing acanthosis in
addition to keratosis. This is not entirely
surprising as there are no precise patho-
logical features to distinguish them.
However, ranking the response oflympho-
cytes to HVH1 according to increasing
values of SI revealed that most
leukoplakias with epithelial atypias were
clustered to that end of the spectrum
which had the highest stimulation indices;
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the corresponding migration indices were
all positive but complement fixing anti-
bodies were raised in some and absent in
others. This finding might be specific to
HVH1, as the SI to C. albicans were
negative in all but I patient and the
migration inhibition activity was not
found in 2 of4 patients with atypia.
An enhanced cell-mediated immune
response to HVH1 in leukoplakia with
epithelial atypia is subject to a number of
interpretations: (1) The virus infection
and epithelial atypia are unrelated events;
(2) the virus may grow preferentially in
tissue with epithelial atypia; a cell surface
antigen may have developed with a
particular moiecular configuration which
may allow selective binding to HVH1
thereby making the cell unusually sus-
ceptible to that virus (Rubin, 1965); (3)
epithelial atypia may be caused directly by
the virus entering the nuclei of epithelial
cells and initiating the cellular changes;
(4) HVH1 might co-operate with another
rnicrobial or chemical agent to induce
epithelial changes, or it might activate
latent RNA oncogenic viruses (Tanaka
and Southam, 1965; Heubner and Todaro,
1969).
These interpretations will be subjected
to experimental studies, though HVHI
has no proven oncogenic properties.
However, it can enhance papilloma and
carcinoma formation when administered
with methylcholanthrene and the virus
may be involved in carcinomatous trans-
formation of papilloma (Tanaka and
Southanm, 1965; Southam et al., 1969).
The fourth interpretation is of particular
interest as DNA viruses or chemical
carcinogens may be involved in derepress-
ing endogenous viral oncogenes (Heubner
and Todaro, 1969). A relationship be-
tween recurrent herpetic infection and
carcinoma of the lip was suggested on
clinical grounds by Wyburn-Mason (1957).
The response to stimulation with C.
albicans oflymphocytes from patients with
atypia was depressed (Fig. 4) and this
relationship was comparable with that
found with autologous leukoplakic homo-
24
genates (Lehner, 1970a), so that it may
represent part of a more general impair-
mentofcellularresponses. The possibility
has also to be considered that infection
with HVH1 might suppress cellular im-
mune reactions to C(. albicans, as has been
reported with measles and influenza virus
(Fireman, Friday and Kumate, 1969;
Reed, Olds and Kisch, 1972). However,
the nonspecific mitogenic response to
PHA was not significantly changed and
this is consistent with the findings of
Fireman et al. (1969).
The response of' lymphocytes to the
nonspecific mitogen PHA was not im-
paired in patients with carcinoma. As all
the carcinomata in this series were at an
early stage of local invasion, the normal
response to PHA is consistent with the
findings of Benezra and Hochman (1971)
that impairment of the PHA response is
related to the stage of carcinoma.
However, lymphocyte transformation was
significantly impaired and it showed a
negative correlation with macrophage
migration inhibition when C. albicans and
HVH1 were used. This suggests that
cell-mediated immune defects can be
detected at an early stage of carcinoma to
apparently unrelated antigens such as C.
albicans and HVH1 but not to a universal
mitogen (PHA).
The possible relationship between
HVH1 and oral leukoplakia and carcinoma
might appear to be similar to that
suggested between genital infection with
HVH2 and cervical carcinoma (Rawls et
al., 1968; Naib et al., 1969; Aurelian,
Royston and Davis, 1970). Careful epi-
demiological studies have shown a signifi-
cantly higher prevalence of antibodies to
HVH2, not only in patients with cervical
carcinoma but also in those with carcinoma
in situ, cervical atypia and in patients who
had a negative cervical cytological test
but subsequently developed carcinoma in
situ (Nahmias et al., 1970); Aurelian et al.,
1970; Catalano and Johnson, 1971). How-
ever, the prevalence of antibodies to
HVIH1 was not significantly increased in
leukoplakia or carcinoma; there was an
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increase in atypia but this failed to reach
a significant level. The titres of IgG class
offluorescent antibodies to C. albicans and
complement fixing antibodies to HVH2,
cytomegalovirus or adenovirus were not
significantly related to any one group of
patients.
A change in leukoplakia from the
stage of keratosis or acanthosis to atypia
may occur, although there is little doubt
that leukoplakia can remain clinically
unchanged for very many years and it may
be assumed that the histology may also
remain unchanged. Carcinomatous trans-
formation ofepithelial atypia has not been
conclusively established in the mouth and
though there is some evidence for this
progression in cervical atypia (Jones et al.,
1967; Koss, 1969) the subject is by no
means settled. Three patients in the
present series had histologically proven
epithelial atypia which was followed 1-3
years later by carcinoma; one ofthem also
showed histological evidence of acanthosis
3 years before the development of atypia.
Preliminary sequential analysis of
patients with leukoplakia supports the
interpretation that during carcinomatous
transformation of epithelial atypia an
increased index of lymphocyte transfor-
mation to HVH1 is followed by a fall in
the response of lymphocytes at the onset
of carcinomatous transformation. Long-
term sequential studies are in progress to
establish the part that immune responses
to HVH1 may play in the aetiology and
prognosis of oral leukoplakia and
carcinoma.
The hypothesis to be investigated is
that the leukoplakia-carcinoma sequence
may show 3 phases. (1) An initiating
phase in which HVHI may participate in
the development of keratosis and acan-
thosis, in an otherwise predisposed patient;
a dissociation between lymphocyte trans-
formation and migration inhibition per-
mits proliferation of HVHI as was
postulated in recurrent herpetic infections
(Wilton et al., 1972). (2) An activating
phase in which specifically enhanced and
prolonged cell mediated responses to
HVH1 might activate derepression of
latent RNA oncogenic viruses resulting in
epithelial atypia (Heubner and Todaro,
1969). This may progress to the carci-
nomatous phase (3) in which invasion is
associated with nonspecific impairment of
cell-mediated immunity as a result of
prolonged viral stimulation.
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